Trial Profile
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Injection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Thromboembolism
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 25 Aug 2011 New trial record